Paroxysmal atrial fibrillation recurrences and quality of life in symptomatic patients: A crossover study of flecainide and pilsicainide
Conclusions This study found no difference in AF frequency or QOL between symptomatic paroxysmal AF patients who received flecainide or pilsicainide.
Source: Journal of Arrhythmia - Category: Cardiology Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Electrocardiogram | Heart | Heart Disease | Study